164 related articles for article (PubMed ID: 23649996)
1. A novel multi-unit tablet for treating circadian rhythm diseases.
Liu Q; Gong Y; Shi Y; Jiang L; Zheng C; Ge L; Liu J; Zhu J
AAPS PharmSciTech; 2013 Jun; 14(2):861-9. PubMed ID: 23649996
[TBL] [Abstract][Full Text] [Related]
2. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
Wang R; Huang G; Fang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
[TBL] [Abstract][Full Text] [Related]
3. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
4. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
Yadav D; Survase S; Kumar N
Int J Pharm; 2011 Oct; 419(1-2):121-30. PubMed ID: 21807081
[TBL] [Abstract][Full Text] [Related]
5. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
Mutalik S; Manoj K; Reddy MS; Kushtagi P; Usha AN; Anju P; Ranjith AK; Udupa N
AAPS PharmSciTech; 2008; 9(2):651-9. PubMed ID: 18500561
[TBL] [Abstract][Full Text] [Related]
6. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
7. Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
Li G; Han D; Guan T; Zhao X; He H; Tang X
Int J Pharm; 2010 Nov; 400(1-2):138-44. PubMed ID: 20826202
[TBL] [Abstract][Full Text] [Related]
8. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].
Liang XD; Zheng Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):559-64. PubMed ID: 20957015
[TBL] [Abstract][Full Text] [Related]
10. Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release.
Del Curto MD; Palugan L; Foppoli A; Zema L; Gazzaniga A; Maroni A
J Pharm Sci; 2014 Nov; 103(11):3585-3593. PubMed ID: 25213173
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
Tian L; Zhang Y; Tang X
Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
14. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
Ghanam D; Kleinebudde P
Int J Pharm; 2011 May; 409(1-2):9-18. PubMed ID: 21335073
[TBL] [Abstract][Full Text] [Related]
15. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
16. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
17. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
Serratoni M; Newton M; Booth S; Clarke A
Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
[TBL] [Abstract][Full Text] [Related]
18. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
Boyapally H; Nukala RK; Douroumis D
Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.
Liu Y; Liu S; Dai Q
Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):55-60. PubMed ID: 19122316
[TBL] [Abstract][Full Text] [Related]
20. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
Khan ZA; Tripathi R; Mishra B
AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
